Effect of Influenza A(H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses
Jennifer L. Nayak(University of Rochester Medicine), Andrea J. Sant(University of Rochester Medical Center), Katherine A. Richards(University of Rochester Medicine), John J. Treanor(University of Rochester Medicine), Hongmei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 57
Related Papers
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
|Cell|2021|309
The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance
|Immunity|2005|232
The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes
|Immunological Reviews|2005|128
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
|The Journal of Experimental Medicine|1995|109
<scp>CD</scp>4 T cells in protection from influenza virus: Viral antigen specificity and functional potential
|Immunological Reviews|2018|93